8251 - 8275 of 8816 Results
Title
Year
-
OPENTitle: Substantia nigra hyperechogenicity with LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 5Start Page: 885End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082617Citation Count: 36
-
RESTRICTEDTitle: Advances in the genetics and pathology of Lewy body dementiaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 24Issue #: 12Start Page: 1026End Page: 1037Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(25)00363-1Citation Count: 1
-
OPENTitle: Unilateral focused ultrasound thalamotomy for tremor-dominant Parkinson’s disease: blinded evaluation and imaging correlationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf303Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf303/64085583/fcaf303.pdfCitation Count: 0
-
OPENTitle: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3116End Page: 3128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz260Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3116/30063806/awz260.pdfCitation Count: 85
-
RESTRICTEDTitle: Teaching program for the Unified Dyskinesia Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 9Start Page: 1296End Page: 1298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22563Citation Count: 11
-
OPENTitle: Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samplesJournal Name: Journal of Chromatography APublisher: Elsevier BVVol: 1446Issue #:Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.chroma.2016.04.006Best OA location URL: http://doi.org/10.1016/j.chroma.2016.04.006Citation Count: 227
-
RESTRICTEDTitle: Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot studyJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 129Issue #:Start Page: 238End Page: 244Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2025.02.032Citation Count: 1
-
RESTRICTEDTitle: Fatigue brain network functional connectivity in Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 579Issue #:Start Page: 122End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2025.06.001Best OA location URL: https://www.ibroneuroscience.org/action/showPdf?pii=S0306452225006748Citation Count: 0
-
OPENTitle: Open-source platforms to investigate analytical flexibility in neuroimagingJournal Name: Imaging NeurosciencePublisher: MIT PressVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1162/imag.a.79Best OA location URL: https://direct.mit.edu/imag/article-pdf/doi/10.1162/IMAG.a.79/2534165/imag.a.79.pdfCitation Count: 0
-
OPENTitle: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 308Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7404626Citation Count: 38
-
OPENTitle: Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational researchJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100339End Page: 100339Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100339Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100339Citation Count: 0
-
OPENTitle: Predicting primary progressive aphasias with support vector machine approaches in structural MRI dataJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 334End Page: 343Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.003Best OA location URL: https://doi.org/10.1016/j.nicl.2017.02.003Citation Count: 50
- Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's disease2017RESTRICTEDTitle: Trial of dextromethorphan/quinidine to treat levodopa‐induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 6Start Page: 893End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26976Citation Count: 34
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39
-
OPENTitle: Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH‐SY5Y cellsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 6Start Page: 950End Page: 961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12497Best OA location URL: http://doi.org/10.1111/jnc.12497Citation Count: 38
-
RESTRICTEDTitle: High priority publications on Parkinson's disease in 2017Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30416-7Citation Count: 0
- PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysis2025OPENTitle: PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysisJournal Name: Software ImpactsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100766End Page: 100766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.simpa.2025.100766Best OA location URL: https://doi.org/10.1016/j.simpa.2025.100766Citation Count: 0
-
OPENTitle: IL-10: A possible immunobiological component of positive mental health in refugeesJournal Name: Comprehensive PsychoneuroendocrinologyPublisher: Elsevier BVVol: 8Issue #:Start Page: 100097End Page: 100097Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cpnec.2021.100097Best OA location URL: https://doi.org/10.1016/j.cpnec.2021.100097Citation Count: 7
-
RESTRICTEDTitle: Impact of inpatient mobility on outcomes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107834End Page: 107834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107834Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107834Citation Count: 0
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo2014OPENTitle: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 5Start Page: 1496End Page: 1513Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu057Best OA location URL: https://academic.oup.com/brain/article-pdf/137/5/1496/11140606/awu057.pdfCitation Count: 220
-
RESTRICTEDTitle: Serum lipid alterations in GBA-associated Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 58End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026Citation Count: 81
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3159957Citation Count: 81
-
RESTRICTEDTitle: Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107854End Page: 107854Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107854Citation Count: 0
-
OPENTitle: Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and olderJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01095-9Best OA location URL: https://www.nature.com/articles/s41531-025-01095-9.pdfCitation Count: 0
- Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trial2011RESTRICTEDTitle: Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trialJournal Name: Basal GangliaPublisher: Elsevier BVVol: 1Issue #: 2Start Page: 91End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.baga.2011.04.002Citation Count: 34